Twinbeech Capital LP Illumina, Inc. Transaction History

Twinbeech Capital LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$101.05 - $133.57 $16.8 Million - $22.2 Million	166,344 New	166,344 $17.4 Million
Q3 2023 Nov 14, 2023	BUY	$128.91 - $192.44 $1.5 Million - $2.24 Million	11,624 New	11,624 $1.6 Million
Q4 2022 Feb 14, 2023	BUY	$187.24 - $242.74 $7.9 Million - $10.2 Million	42,194 New	42,194 $8.53 Million
Q2 2022 Aug 15, 2022	BUY	$181.58 - $368.0 $24.3 Million - $49.3 Million	133,932 New	133,932 $24.7 Million
Q4 2021 Feb 14, 2022	SELL	$347.28 - $421.83 $4.85 Million - $5.89 Million	-13,974 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$405.61 - $524.84 $5.67 Million - $7.33 Million	13,974 New	13,974 $5.67 Million
Q2 2021 Aug 16, 2021	SELL	$372.84 - $481.5 $7.11 Million - $9.18 Million	-19,071 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$361.28 - $504.76 $6.89 Million - $9.63 Million	19,071 New	19,071 $7.32 Million

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.